Charlie Petty

Charlie Petty serves as a Partner and Managing Director at Global Health Investment Corporation since 2022 and is a Board Member and Board Observer at Centivax since 2023. As a Co-Founder of Adjuvant Capital since 2018, Charlie has been pivotal in establishing a life sciences venture capital firm dedicated to global public health. Additional roles include Board Director positions at Curevo Vaccine and Blueprint Biosecurity, along with Board Observer roles at Vaxess Technologies, Monod Bio, and ENDPOINT HEALTH. Charlie contributes to literary pursuits as a Board Member of Bellevue Literary Press, effective April 2024. Educational qualifications include studies at Virginia Tech, participation in Space Camp, and completion of microeconomics, corporate finance, and financial modeling at Dartmouth College's Tuck Bridge program.